The biggest risk to the stability and potency of Semaglutide and B12 comes from improper storage, particularly exposure to temperatures outside the recommended range
ExitCare 2012
For a long time, traditional approaches often focused solely on diet and exercise, which, while vital, frequently fell short for individuals whose biology and metabolism were working against them
For dulaglutide users, the corresponding follow-up was, on average, 173 days (median 139 days, IQR 73 to 257 days)
A subset of patients (roughly 18%) report increased fatigue during the first month on tirzepatide, possibly related to the metabolic shift in fat oxidation
If you are pursuing a long-term health transformation, you need realistic insights